Item 15. Exhibit and Financial Statement Schedules

**(a)**The following documents are filed as part of this report:

(1) Financial Statements:


			Page(s)
Report of Independent Registered Public Accounting Firm — PricewaterhouseCoopers LLP			56
Consolidated Statement of Income for the three years ended December 31, 2021			58
Consolidated Statement of Comprehensive Income for the three years ended December 31, 2021			59
Consolidated Balance Sheet at December 31, 2021 and 2020			60
Consolidated Statement of Cash Flows for the three years ended December 31, 2021			61
Consolidated Statement of Equity for the three years ended December 31, 2021			62
Notes to the Consolidated Financial Statements			63 to 96

(2) Financial Statement Schedules:

Included below is Schedule II - Valuation and Qualifying Accounts for each of the three years in the period ended December 31, 2021.

(3) Exhibits:

The Exhibit Index on the following pages lists the exhibits that are filed as part of this report.

Schedule II — Valuation and Qualifying Accounts


	Year ended December 31
Millions of Dollars	2021		2020		2019
Employee Termination Benefits
Balance at January 1	$	470	$	7	$	19
Additions (reductions) charged to expense	(30)		859		6
Payments	(397)		(396)		(18)
Balance at December 31	$	43	$	470	$	7
Expected Credit Losses
Beginning allowance balance for expected credit losses	$	671	$	849	$	980
Current period provision	74		573		(128)

Write-offs charged against the allowance, if any	—		(751)		(3)

Balance at December 31	$	745	$	671	$	849
Deferred Income Tax Valuation Allowance1
Balance at January 1	$	17,762	$	15,965	$	15,973
Additions to deferred income tax expense2	3,691		2,892		1,336
Reduction of deferred income tax expense	(3,802)		(1,095)		(1,344)
Balance at December 31	$	17,651	$	17,762	$	15,965

2 Includes $974 of additions associated with the purchase of Noble in 2020.